RBC Capital analyst Craig Wong-Pan maintained a Hold rating on Resmed (RMD – Research Report) on January 29 and set a price target of $238.00.

Imposing higher capital requirements on UBS as a systemically relevant bank will usher in higher costs for companies and ...

Britain’s biggest supermarket chain used data to gain an edge, but as rivals start to catch up, Michael Fahy looks at whether its growth prospects are worth buying into ...

That helps underscore UBS analyst Joseph Spak's belief that investors don't really view Tesla (TSLA) as a carmaker any more. "We can almost definitively say the market doesn't treat TSLA like an auto ...

RBC Capital analyst Nik Modi maintained a Hold rating on Energizer Holdings (ENR – Research Report) today and set a price target of $38.00. The ...

UBS implements Azure-based assistant to 30,000 staff in Asian and European booking centres through enterprise-scale ...

DGS Capital Management LLC grew its stake in shares of JPMorgan Chase & Co. (NYSE:JPM) by 5.0% in the fourth quarter, ...

UBS analyst Susy Tibaldi updated the financial outlook for EssilorLuxottica SA (EL:FP) (OTC: OTC:ESLOY), increasing the price ...

Prologis (NYSE:PLD – Get Free Report) had its price target raised by UBS Group from $121.00 to $137.00 in a research report ...

Bonnici was a managing director at RBC and led several high-profile deals across infrastructure and technology during his ...

The Adam Watson-led APA is understood to be instead focusing – at this time – on organic opportunities within its existing ...

Q4 2024 Earnings Conference Call January 29, 2025 11:00 AM ETCompany ParticipantsJeremy Ulan – Head-Investor Relations ...